Cabello-Ubeda A, de Quiros JCLB, Martin Carbonero L, Sanz J, et al. 48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naive adults living with HIV: A multicenter real-life cohort. PLoS One 2022;17:e0277606.
PMID: 36409695